Insulin aspart, recombinant Subcutaneous and Methyl Aminolevulinate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Methyl Aminolevulinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: methyl aminolevulinate topical
Brand name: Metvixia
Synonyms: Methyl aminolevulinate (topical)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Methyl aminolevulinate topical
- Insulin aspart, recombinant Subcutaneous-Methyl aminolevulinate Topical application
- Insulin aspart, recombinant Subcutaneous-Methyl B-12 vitamin B12
- Insulin aspart, recombinant Subcutaneous-Methyl Salicylate and Menthol Cream and Ointment
- Insulin aspart, recombinant Subcutaneous-Methyl Salicylate and Menthol Lotion
- Insulin aspart, recombinant Subcutaneous-Methyl salicylate topical
- Methyl Aminolevulinate-Insulin degludec
- Methyl Aminolevulinate-Insulin Degludec (U-100) Prefilled Pens
- Methyl Aminolevulinate-Insulin Degludec (U-100) Vials
- Methyl Aminolevulinate-Insulin Degludec (U-200) Prefilled Pens
- Methyl Aminolevulinate-Insulin degludec and liraglutide
- Methyl Aminolevulinate-Insulin degludec and liraglutide Subcutaneous